284 related articles for article (PubMed ID: 24637810)
21. [GENETICALLY DETERMINED DISEASES ASSOCIATED WITH PATHOLOGICAL BRAIN IRON ACCUMULATION AND NEURODEGENERATION].
Ács P; Molnár MJ; Klivényi P; Kálmán B
Ideggyogy Sz; 2016 Mar; 69(5-6):157-66. PubMed ID: 27468605
[TBL] [Abstract][Full Text] [Related]
22. Analysis of ATP13A2 in large neurodegeneration with brain iron accumulation (NBIA) and dystonia-parkinsonism cohorts.
Kruer MC; Paudel R; Wagoner W; Sanford L; Kara E; Gregory A; Foltynie T; Lees A; Bhatia K; Hardy J; Hayflick SJ; Houlden H
Neurosci Lett; 2012 Aug; 523(1):35-8. PubMed ID: 22743658
[TBL] [Abstract][Full Text] [Related]
23. Classification and molecular pathogenesis of NBIA syndromes.
Di Meo I; Tiranti V
Eur J Paediatr Neurol; 2018 Mar; 22(2):272-284. PubMed ID: 29409688
[TBL] [Abstract][Full Text] [Related]
24. Retrospective analysis of 17 patients with mitochondrial membrane protein-associated neurodegeneration diagnosed in Russia.
Sparber P; Krylova T; Repina S; Demina N; Rudenskaya G; Sharkova I; Sharkov A; Kadyshev V; Kanivets I; Korostelev S; Pomerantseva E; Kaimonov V; Mikhailova S; Zakharova E; Skoblov M
Parkinsonism Relat Disord; 2021 Mar; 84():98-104. PubMed ID: 33607528
[TBL] [Abstract][Full Text] [Related]
25. Neurodegeneration with Brain Iron Accumulation: Two Additional Cases with Dystonic Opisthotonus.
Mehta S; Lal V
Tremor Other Hyperkinet Mov (N Y); 2019; 9():. PubMed ID: 31489256
[TBL] [Abstract][Full Text] [Related]
26. Is there heart disease in cases of neurodegeneration associated with mutations in C19orf12?
Skowronska M; Buksinska-Lisik M; Kmiec T; Litwin T; Kurkowska-Jastrzębska I; Czlonkowska A
Parkinsonism Relat Disord; 2020 Nov; 80():15-18. PubMed ID: 32932022
[TBL] [Abstract][Full Text] [Related]
27. Autosomal dominant mitochondrial membrane protein-associated neurodegeneration (MPAN).
Gregory A; Lotia M; Jeong SY; Fox R; Zhen D; Sanford L; Hamada J; Jahic A; Beetz C; Freed A; Kurian MA; Cullup T; van der Weijden MCM; Nguyen V; Setthavongsack N; Garcia D; Krajbich V; Pham T; Woltjer R; George BP; Minks KQ; Paciorkowski AR; Hogarth P; Jankovic J; Hayflick SJ
Mol Genet Genomic Med; 2019 Jul; 7(7):e00736. PubMed ID: 31087512
[TBL] [Abstract][Full Text] [Related]
28. Lifetime risk of autosomal recessive neurodegeneration with brain iron accumulation (NBIA) disorders calculated from genetic databases.
Kolarova H; Tan J; Strom TM; Meitinger T; Wagner M; Klopstock T
EBioMedicine; 2022 Mar; 77():103869. PubMed ID: 35180557
[TBL] [Abstract][Full Text] [Related]
29. Retinal and optic nerve abnormalities in neurodegeneration associated with mutations in C19orf12 (MPAN).
Langwinska-Wosko E; Skowronska M; Kmiec T; Czlonkowska A
J Neurol Sci; 2016 Nov; 370():237-240. PubMed ID: 27772766
[TBL] [Abstract][Full Text] [Related]
30. Dominant mitochondrial membrane protein-associated neurodegeneration (MPAN) variants cluster within a specific C19orf12 isoform.
Rickman OJ; Salter CG; Gunning AC; Fasham J; Voutsina N; Leslie JS; McGavin L; Cross HE; Posey JE; Akdemir ZC; Jhangiani SN; Lupski JR; Baple EL; Crosby AH
Parkinsonism Relat Disord; 2021 Jan; 82():84-86. PubMed ID: 33260061
[TBL] [Abstract][Full Text] [Related]
31. PANK2 gene analysis confirms genetic heterogeneity in neurodegeneration with brain iron accumulation (NBIA) but mutations are rare in other types of adult neurodegenerative disease.
Matarin MM; Singleton AB; Houlden H
Neurosci Lett; 2006 Oct; 407(2):162-5. PubMed ID: 16962235
[TBL] [Abstract][Full Text] [Related]
32. Neurodegeneration with brain iron accumulation.
Wiethoff S; Houlden H
Handb Clin Neurol; 2017; 145():157-166. PubMed ID: 28987166
[TBL] [Abstract][Full Text] [Related]
33. A novel FTL mutation responsible for neuroferritinopathy with asymmetric clinical features and brain anomalies.
Moutton S; Fergelot P; Trocello JM; Plante-Bordeneuve V; Houcinat N; Wenisch E; Larue V; Brugières P; Clot F; Lacombe D; Arveiler B; Goizet C
Parkinsonism Relat Disord; 2014 Aug; 20(8):935-7. PubMed ID: 24907184
[No Abstract] [Full Text] [Related]
34. Neurodegeneration with brain iron accumulation: clinical, radiographic and genetic heterogeneity and corresponding therapeutic options.
Clement F; Devos D; Moreau C; Coubes P; Destee A; Defebvre L
Acta Neurol Belg; 2007 Mar; 107(1):26-31. PubMed ID: 17569231
[TBL] [Abstract][Full Text] [Related]
35. The p.Thr11Met mutation in c19orf12 is frequent among adult Turkish patients with MPAN.
Olgiati S; Doğu O; Tufekcioglu Z; Diler Y; Saka E; Gultekin M; Kaleagasi H; Kuipers D; Graafland J; Breedveld GJ; Quadri M; Sürmeli R; Sünter G; Doğan T; Yalçın AD; Bilgiç B; Elibol B; Emre M; Hanagasi HA; Bonifati V
Parkinsonism Relat Disord; 2017 Jun; 39():64-70. PubMed ID: 28347615
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and safety of deferiprone for the treatment of pantothenate kinase-associated neurodegeneration (PKAN) and neurodegeneration with brain iron accumulation (NBIA): results from a four years follow-up.
Cossu G; Abbruzzese G; Matta G; Murgia D; Melis M; Ricchi V; Galanello R; Barella S; Origa R; Balocco M; Pelosin E; Marchese R; Ruffinengo U; Forni GL
Parkinsonism Relat Disord; 2014 Jun; 20(6):651-4. PubMed ID: 24661465
[TBL] [Abstract][Full Text] [Related]
37. Novel WDR45 Mutation and Pathognomonic BPAN Imaging in a Young Female With Mild Cognitive Delay.
Long M; Abdeen N; Geraghty MT; Hogarth P; Hayflick S; Venkateswaran S
Pediatrics; 2015 Sep; 136(3):e714-7. PubMed ID: 26240209
[TBL] [Abstract][Full Text] [Related]
38. Neurodegeneration with brain iron accumulation.
McNeill A; Chinnery PF
Handb Clin Neurol; 2011; 100():161-72. PubMed ID: 21496576
[TBL] [Abstract][Full Text] [Related]
39. High frequency of beta-propeller protein-associated neurodegeneration (BPAN) among patients with intellectual disability and young-onset parkinsonism.
Nishioka K; Oyama G; Yoshino H; Li Y; Matsushima T; Takeuchi C; Mochizuki Y; Mori-Yoshimura M; Murata M; Yamasita C; Nakamura N; Konishi Y; Ohi K; Ichikawa K; Terada T; Obi T; Funayama M; Saiki S; Hattori N
Neurobiol Aging; 2015 May; 36(5):2004.e9-2004.e15. PubMed ID: 25744623
[TBL] [Abstract][Full Text] [Related]
40. Early manifestations of epileptic encephalopathy, brain atrophy, and elevation of serum neuron specific enolase in a boy with beta-propeller protein-associated neurodegeneration.
Takano K; Goto K; Motobayashi M; Wakui K; Kawamura R; Yamaguchi T; Fukushima Y; Kosho T
Eur J Med Genet; 2017 Oct; 60(10):521-526. PubMed ID: 28711740
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
